Dr. Linda Van Eldik, left, Caleb Bailey, and McKenna Green working in the lab on May 15, 2026. Photo by Mark Cornelison | UKphoto
A new study from researchers at the University of Kentucky’s Sanders-Brown Center on Aging is exploring whether a drug originally developed to combat neuroinflammation in dementia could also help reduce the harmful brain inflammation associated with alcohol withdrawal — a discovery that could eventually open new treatment pathways for alcohol use disorder. Dr. Greg talks with Caleb Bailey, Ph.D., co-author of the study.
Dr. Greg Davis is a forensic pathologist with UK HealthCare. Every week, Davis speaks with local health providers, professionals, and researchers on Dr. Greg Davis on Medicine.